Comparison of a combination of 5-fluorouracil (NSC-19893), mitomycin C (NSC-26980), triethylenethiophosphoramide (NSC-6396), and fluoxymesterone (NSC-12165) with 5-fluorouracil alone in patients with advanced cancer.
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D005472:Fluorouracil / Q000627:therapeutic use; D005474:Fluoxymesterone / Q000627:therapeutic use; D006801:Humans; D008937:Mitomycins / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy; D013852:Thiotepa / Q000008:administration & dosage
D000970:Antineoplastic Agents; D008937:Mitomycins; D013852:Thiotepa; D005474:Fluoxymesterone; D005472:Fluorouracil